Loading...
Exponent's first quarter results for 2024 showed revenue growth with revenues before reimbursements increasing by 6.6% to $137.2 million. Net income increased to $30.1 million, or $0.59 per diluted share.
Revenues before reimbursements increased by 6.6% to $137.2 million.
Net income increased to $30.1 million, or $0.59 per diluted share.
Engineering and other scientific segment revenues before reimbursements increased by 8%.
Environmental and health segment revenues before reimbursements increased by 1%.
Exponent anticipates strong core market dynamics and enduring value proposition.
Visualization of income flow from segment revenue to net income